Caricamento...
Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
Rectal use of a 1% tenofovir (TFV) gel is currently being evaluated for HIV prevention. While careful assessment of mucosal safety of candidate microbicides is a primary concern, tools to assess mucosal toxicity are limited. Mass spectrometry-based proteomics is a sensitive and high-throughput techn...
Salvato in:
| Pubblicato in: | AIDS Res Hum Retroviruses |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5067863/ https://ncbi.nlm.nih.gov/pubmed/27316778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2015.0381 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|